Molecular studies showed that overexpression of RSK4 could enhance the invasive and migratory abilities of ccRCC cell lines through the regulation of CD44 and MMP-9 expression and vice versa. This evidence concerns the gene RPS6KA6 and nonpapillary renal cell carcinoma.